Alzheimer's Research & Therapy, 1758-9193

Journal

More filtering options
  1. Cerebrovascular and amyloid pathology in predementia stages: The relationship with neurodegeneration and cognitive decline

    Bos, I., Verhey, F. R., Ramakers, I. H. G. B., Jacobs, H. I. L., Soininen, H., Freund-Levi, Y., Hampel, H., Tsolaki, M., Åsa K. Wallin, Van Buchem, M. A., Oleksik, A., Verbeek, M. M., Olde Rikkert, M., Van Der Flier, W. M., Scheltens, P., Aalten, P., Visser, P. J. & Vos, S. J. B., 2017 Dec 29, In : Alzheimer's Research and Therapy. 9, 1, 101.

    Research output: Contribution to journalArticle

  2. Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease: Protocol of the BEAT-IT study

    Eikelboom, W. S., Singleton, E., Van Den Berg, E., Coesmans, M., Mattace Raso, F., Van Bruchem, R. L., Goudzwaard, J. A., De Jong, F. J., Koopmanschap, M., Den Heijer, T., Driesen, J. J. M., Vroegindeweij, L. J. H. M., Thomeer, E. C., Hoogers, S. E., Dijkstra, A. A., Zuidema, S. U., Pijnenburg, Y. A. L., Scheltens, P., Van Swieten, J. C., Ossenkoppele, R. & 1 othersPapma, J. M., 2019, In : Alzheimer's Research and Therapy. 11, 1, 48.

    Research output: Contribution to journalArticle

  3. Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.

    Oskar Hansson, Sara Hall, Ohrfelt, A., Zetterberg, H., Blennow, K., Lennart Minthon, Katarina Nägga, Elisabet Londos, Varghese, S., Majbour, N. K., Al-Hayani, A. & El-Agnaf, O. M., 2014, In : Alzheimer's Research & Therapy. 6, 3, 25.

    Research output: Contribution to journalArticle

  4. Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

    Oskar Hansson, Lehmann, S., Otto, M., Zetterberg, H. & Lewczuk, P., 2019 Apr 22, In : Alzheimer's Research and Therapy. 11, 1, p. 1-15 15 p.

    Research output: Contribution to journalReview article

  5. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease

    Henjum, K., Almdahl, I. S., Årskog, V., Lennart Minthon, Oskar Hansson, Fladby, T. & Nilsson, L. N. G., 2016, In : Alzheimer's Research & Therapy. 8, 1, 182.

    Research output: Contribution to journalArticle

  6. Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.

    Jekel, K., Damian, M., Wattmo, C., Hausner, L., Bullock, R., Connelly, P. J., Dubois, B., Eriksdotter, M., Ewers, M., Graessel, E., Kramberger, M. G., Law, E., Mecocci, P., Molinuevo, J. L., Nygård, L., Olde-Rikkert, M. G., Orgogozo, J-M., Pasquier, F., Peres, K., Salmon, E. & 6 othersSikkes, S. A., Sobow, T., Spiegel, R., Tsolaki, M., Winblad, B. & Frölich, L., 2015, In : Alzheimer's Research & Therapy. 7, 1, 17.

    Research output: Contribution to journalReview article

  7. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

    Kvartsberg, H., Portelius, E., Andreasson, U., Brinkmalm, G., Hellwig, K., Lelental, N., Kornhuber, J., Oskar Hansson, Lennart Minthon, Spitzer, P., Maler, J. M., Zetterberg, H., Blennow, K. & Lewczuk, P., 2015, In : Alzheimer's Research & Therapy. 7, 1, 40.

    Research output: Contribution to journalArticle

  8. Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations

    Lautner, R., Philip S. Insel, Skillbäck, T., Olsson, B., Landén, M., Frisoni, G. B., Herukka, S-K., Hampel, H., Wallin, A., Lennart Minthon, Oskar Hansson, Blennow, K., Niklas Mattsson & Zetterberg, H., 2017 Oct 23, In : Alzheimer's Research and Therapy. 9, 1, 87.

    Research output: Contribution to journalArticle

  9. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

    Öhrfelt, A., Brinkmalm, A., Dumurgier, J., Brinkmalm, G., Oskar Hansson, Zetterberg, H., Bouaziz-Amar, E., Hugon, J., Paquet, C. & Blennow, K., 2016 Oct 3, In : Alzheimer's Research & Therapy. 8, 1, 10 p.

    Research output: Contribution to journalArticle

  10. Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease

    Patra, K., Soosaipillai, A., Sando, S. B., Lauridsen, C., Berge, G., Møller, I., Grøntvedt, G. R., Bråthen, G., Begcevic, I., Moussaud, S., Lennart Minthon, Oskar Hansson, Diamandis, E. P., White, L. R. & Nielsen, H. M., 2018, In : Alzheimer's Research and Therapy. 10, 1, 9.

    Research output: Contribution to journalArticle

  11. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: A 22-year follow-up study

    Thordardottir, S., Rodriguez-Vieitez, E., Almkvist, O., Ferreira, D., Saint-Aubert, L., Kinhult-Ståhlbom, A., Thonberg, H., Michael Schöll, Westman, E., Wall, A., Eriksdotter, M., Zetterberg, H., Blennow, K., Nordberg, A. & Graff, C., 2018 May 10, In : Alzheimer's Research and Therapy. 10, 1, 45.

    Research output: Contribution to journalArticle

  12. Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum

    Timmers, T., Rik Ossenkoppele, Wolters, E. E., Verfaillie, S. C. J., Visser, D., Golla, S. S. V., Barkhof, F., Scheltens, P., Boellaard, R., Van Der Flier, W. M. & Van Berckel, B. N. M., 2019 Jul 4, In : Alzheimer's Research and Therapy. 11, 1, 60.

    Research output: Contribution to journalArticle

  13. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)

    Vanderstichele, H., Demeyer, L., Shorena Janelidze, Coart, E., Stoops, E., Mauroo, K., Herbst, V., François, C. & Oskar Hansson, 2017 Jun 6, In : Alzheimer's Research and Therapy. 9, 1, 40.

    Research output: Contribution to journalArticle

  14. Is intracranial volume a suitable proxy for brain reserve? Rik Ossenkoppele

    Van Loenhoud, A. C., Groot, C., Vogel, J. W., Van Der Flier, W. M. & Rik Ossenkoppele, 2018 Sep 11, In : Alzheimer's Research and Therapy. 10, 1, 91.

    Research output: Contribution to journalReview article

  15. Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application

    Carina Wattmo, Jedenius, E., Blennow, K. & Åsa Wallin, 2013, In : Alzheimer's Research & Therapy. 5, 1, 2.

    Research output: Contribution to journalArticle

  16. Plasma tau levels in Alzheimer's disease

    Zetterberg, H., Wilson, D., Andreasson, U., Lennart Minthon, Blennow, K., Randall, J. & Oskar Hansson, 2013, In : Alzheimer's Research & Therapy. 5, 2, 9.

    Research output: Contribution to journalLetter